Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Sarah Heflin's research focuses on investigating novel therapeutic strategies for breast cancer, with a particular emphasis on targeting stem-like cells. Her work involves the synthesis and evaluation of modified salinomycin analogs. These compounds have demonstrated the ability to target these specific cancer cells in both two-dimensional and three-dimensional breast cancer models. Heflin has published one study in this area, contributing to the understanding of how drug modifications can enhance efficacy against resistant cancer populations. Her scholarly output, though limited in volume, is supported by collaborative efforts within the University of Arkansas for Medical Sciences, including shared publications with Robert L. Eoff, Melanie Clair Macnicol, Angus M. MacNicol, and Alicja Urbaniak.
Metrics
- h-index: 1
- Publications: 1
- Citations: 13
Selected Publications
-
Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models (2021)
Collaboration Network
Top Collaborators
- Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models
- Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models
- Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models
- Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models
- Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models
- Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models
- Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models
- Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models
- Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models
- Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models
- Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models
- Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models
Similar Researchers
Based on overlapping research topics